Benzodiazepine derivatives as GABA a GAMMA1 PAM
US12344614B2 · kind B2 · utility
0Cited by
9References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2022 |
| Grant date | Jul 1, 2025 |
| Priority date | — |
| Expiry date | Feb 18, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D243/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides novel heterocyclic compounds having the general formula (I) or (II), and pharmaceutically acceptable salts thereof, wherein the variables are as described herein.Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds for the treatment or prevention of acute neurological disorders, chronic neurological disorders and/or cognitive disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.